Percutaneous Aponeurotomy in the Treatment of Dupuytren's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2020-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The efficiency of percutaneous aponeurotomy in the treatment of Dupuytrens disease is well known. However, the duration of the clinical improvement after aponeurotomy is not well known.

This study aims primarily at measuring the incidence rate of local relapse of Dupuytrens-induced finger flessum, within two years following treatment by percutaneous aponeurotomy in Dupuytrens.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of Percutaneous Needle Aponeurotomy

NCT03797690

Dupuytren Disease of Finger

RECRUITING NA

Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease

NCT05067764

Dupuytren's Disease

RECRUITING NA

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

NCT02647619

Dupuytren Contracture

COMPLETED PHASE4

Tolerance and Efficacy Study of Second-line Surgery After Percutaneous Needle Aponeurotomy for Dupuytren's Disease.

NCT04164953

Dupuytren's Disease Surgical Incision

UNKNOWN NA

Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease

NCT03000114

Dupuytren Contracture Dupuytren's Disease of Finger

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dupuytren Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Percutaneous aponeurotomy

Treatment of Dupuytrens-induced finger flessum using percutaneous aponeurotomy

Group Type EXPERIMENTAL

Percutaneous aponeurotomy

Intervention Type PROCEDURE

The finger(s) with limited extension due to Dupuytrens disease and for which the patient desires treatment, will be treated by fine-needle percutaneous aponeurotomy under local anesthesia (outpatient procedure). This procedure is already routinely used in clinical practice ; our study aims at better describing the time-sustainability of its benefits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous aponeurotomy

The finger(s) with limited extension due to Dupuytrens disease and for which the patient desires treatment, will be treated by fine-needle percutaneous aponeurotomy under local anesthesia (outpatient procedure). This procedure is already routinely used in clinical practice ; our study aims at better describing the time-sustainability of its benefits.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient suffers from Dupuytren disease
* Patient has at least one finger with at least 20° flessum on the metacarpophalangeal joint and/or on the proximal interphalangeal joint
* Patient has chosen to benefit from local treatment